STMN1 and non-small cell lung carcinoma: Kaplan–Meier survival analysis showed that STMN1 positive was significantly (p=0.006) associated with a poorer prognosis of NSCLC patients who received postoperative adjuvant chemotherapy, which was consistent with our results.